Optiver Holding’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.8M Buy
+95,433
New +$18.4M 0.71% 287
2025
Q4
Sell
-11,638
Closed -$2.04M 2503
2025
Q3
$1.79M Buy
+11,638
New +$1.76M 0.03% 405
2025
Q2
Sell
-276,006
Closed -$38.7M 1466
2025
Q1
$40.6M Buy
+276,006
New +$39.9M 1.57% 106
2024
Q4
Sell
-112,175
Closed -$15.7M 1047
2024
Q3
$17.5M Sell
112,175
-35,638
-24% -$5.75M 0.44% 194
2024
Q2
$23.1M Buy
+147,813
New +$22.2M 0.44% 202
2024
Q1
Sell
-540,495
Closed -$71.6M 677
2023
Q4
$72.9M Buy
540,495
+210,061
+64% +$27.3M 2.18% 128
2023
Q3
$44.8M Buy
330,434
+169,105
+105% +$23.1M 1.28% 148
2023
Q2
$23.1M Sell
161,329
-236,582
-59% -$34.8M 0.67% 211
2023
Q1
$55.1M Buy
397,911
+208,677
+110% +$28.1M 2.55% 150
2022
Q4
$25.7M Sell
189,234
-11,714
-6% -$1.47M 1.56% 179
2022
Q3
$22.2M Buy
+200,948
New +$25.5M 1.54% 142
2022
Q2
Sell
-40,425
Closed -$5.3M 375
2022
Q1
$5.36M Sell
40,425
-386,613
-91% -$46.4M 0.4% 163
2021
Q4
$49.8M Buy
+427,038
New +$50.2M 2.23% 96
2021
Q3
Hold
0
726
2021
Q2
Sell
-380,807
Closed -$41.8M 519
2021
Q1
$37.9M Buy
+380,807
New +$38.3M 4.42% 49

Other funds holding AZN